Lv3
230 积分 2020-07-29 加入
Angiopoietin-like protein 3 inhibitors and contemporary unmet needs in lipid management
8天前
已完结
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial
8天前
已完结
1532 MINIMAL CLINICALLY IMPORTANT DIFFERENCES (MCID) IN THE ERECTILE FUNCTION (EF) DOMAIN OF THE INTERNATIONAL INDEX OF ERECTILE FUNCTION (IIEF)
11天前
已完结
Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment of Erectile Dysfunction
12天前
已完结
Food and Drug Administration's Obesity Drug Guidance Document
13天前
已完结
Clinical Trial: Plozasiran Prevents Recurrent Pancreatitis in Adults With Very Severe Hypertriglyceridemia—Results of a Post Hoc Analysis of the Phase 3 PALISADE Study
14天前
已完结
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
14天前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
24天前
已完结
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
26天前
已完结
Inclisiran: A Novel Agent for Lowering Apolipoprotein B–containing Lipoproteins
26天前
已完结
皖公网安备34019202002308
